Breaking News

Apicore’s Somerset Site Gets Second Successful FDA Inspection

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The FDA completed an inspection of Apicore LLC‘s kilo-scale API manufacturing site in Somerset, NJ. The inspection took place December 12-15, 2008, according to Compliance Program 7356.002F, “Drug Manufacturing Inspections for Bulk Pharmaceutical Chemicals.” This was the second successful inspection of the site since 2006. Apicore provides process development and manufacturing services according to ICH guidelines for new chemical entities (NCE) and existing APIs for off-patent drug prod...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters